Latest News
BrightFocus-funded researchers have proposed a new way to treat Alzheimer’s, by clearing toxic tau from the connections, or synapses, between brain cells.
BrightFocus is funding early science behind a promising new technology– a wearable device that provides a very early prediction of Alzheimer’s onset.
Researchers uncover a potential association between an APOE genetic variant and changes in brain metabolism leading to increased risk of Alzheimer’s disease and cognitive impairment.
Age-related macular degeneration is thought to begin with a combination of genetic and environmental risk factors that damage retinal cells and lead to the formation of small droplets that may be precursors to drusen. In early studies drugs that inhibit cholesterol help prevent this.
Learn about a key lifestyle change that could help decrease your risk for developing the devastating eye disease
